Literature DB >> 6880625

Influence of systemic factors on experimental epileptic brain injury. Structural changes accompanying bicuculline-induced seizures in rats following manipulations of tissue oxygenation or alpha-tocopherol levels.

B Söderfeldt, G Blennow, H Kalimo, Y Olsson, B K Siesjö.   

Abstract

A previous study from the laboratory showed that status epilepticus induced by bicuculline administration to ventilated rats produced astrocytic swelling and nerve cell changes ("type 1 and 2 injury") particularly in layers 3 and 5 of the neocortex (Söderfeldt et al. 1981). The type 1 injured neurons were characterized by condensation of cyto- and karyoplasm and the less common type 2 cells were characterized by swelling of endoplasmic reticulum including the nuclear envelope. In the present study we explored whether changes in cerebral oxygen availability altered the extent or character of the cellular alterations. Animals with 2 h of status epilepticus were made either hyperoxic (administration of 100% O2), hypoxic (arterial pO2 50 mm Hg) or hypotensive (arterial blood pressure of either 70-75 or 50 mm Hg). Furthermore, we explored whether "oxidative" damage occurred by manipulating tissue levels of alpha-tocopherol, a known free radical scavenger. Non-epileptic control animals exposed to comparable degrees of hypoxia or hypotension showed no or minimal structural alterations. In the epileptic animals the results were as follows. Hyperoxia did not change the quality or extent of the structural alterations previously observed in normoxic epileptic animals. Neither administration nor deficiency of vitamin E did modify this pattern of alterations. In hypoxia the extent of cell damage was the same or somewhat larger than in normoxic, epileptic animals. In addition, neurons often showed cytoplasmic microvacuoles due to swelling of mitochondria. The hypoxic animals also showed swelling of astrocytic nuclei with clumped chromatin. Changes similar to those observed in hypoxic animals also appeared in moderate hypotension (mean arterial blood pressure 50 mm Hg), whereas mild hypotension (70-75 mm Hg) did not change the character of the tissue injury from that seen in hyperoxic or normoxic epileptic rats. The present results demonstrate that the neuronal cell damage that can be observed when the brain is fixed by perfusion after status epilepticus of 2 h duration is not exaggerated by hyperoxia or vitamin E deficiency nor is it ameliorated by a moderate restriction in cerebral oxygen supply or by vitamin E administration. If anything, hypoxia (or moderate hypotension) appears to increase the extent of damage and it clearly alters its ultrastructural characteristics. However, although the results fail to support the notion that epileptic cell damage is "oxidative", definite conclusions must await information on the cell damage that remains upon arrest of the epileptic activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6880625     DOI: 10.1007/bf00685351

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  17 in total

Review 1.  Mechanisms of action of selenium and vitamin E in protection of biological membranes.

Authors:  G F Combs; T Noguchi; M L Scott
Journal:  Fed Proc       Date:  1975-10

2.  Cerebral metabolic changes during prolonged epileptic seizures in rats.

Authors:  A G Chapman; B S Meldrum; B K Siesjö
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

3.  THE NEUROPATHOLOGY OF STATUS EPILEPTICUS.

Authors:  R M NORMAN
Journal:  Med Sci Law       Date:  1964-01       Impact factor: 1.266

4.  Ultrastructural changes in chick cerebellum induced by vitamin E deficiency.

Authors:  P A Young; J J Taylor; W H Yu; M C Yu; L L Tureen
Journal:  Acta Neuropathol       Date:  1973-07-11       Impact factor: 17.088

Review 5.  Cell damage in the brain: a speculative synthesis.

Authors:  B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

6.  Pathogenesis of brain lesions caused by experimental epilepsy. Light- and electron-microscopic changes in the rat cerebral cortex following bicuculline-induced status epilepticus.

Authors:  B Söderfeldt; H Kalimo; Y Olsson; B Siesjö
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism.

Authors:  G Blennow; J B Brierley; B S Meldrum; B K Siesjö
Journal:  Brain       Date:  1978-12       Impact factor: 13.501

8.  Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations.

Authors:  U Ito; M Spatz; J T Walker; I Klatzo
Journal:  Acta Neuropathol       Date:  1975-08-27       Impact factor: 17.088

9.  Brain lactic acidosis and ischemic cell damage: 2. Histopathology.

Authors:  H Kalimo; S Rehncrona; B Söderfeldt; Y Olsson; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

10.  Temporal profile of neuronal damage in a model of transient forebrain ischemia.

Authors:  W A Pulsinelli; J B Brierley; F Plum
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

View more
  3 in total

1.  Bicuculline-induced epileptic brain injury. Transient and persistent cell changes in rat cerebral cortex in the early recovery period.

Authors:  B Söderfeldt; H Kalimo; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

2.  Decreased calmodulin kinase activity after status epilepticus.

Authors:  J Bronstein; D Farber; C Wasterlain
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

3.  A companion to the preclinical common data elements for physiologic data in rodent epilepsy models. A report of the TASK3 Physiology Working Group of the ILAE/AES Joint Translational Task Force.

Authors:  Jan A Gorter; Erwin A van Vliet; Stefanie Dedeurwaerdere; Gordon F Buchanan; Daniel Friedman; Karin Borges; Heidi Grabenstatter; Katarzyna Lukasiuk; Helen E Scharfman; Astrid Nehlig
Journal:  Epilepsia Open       Date:  2018-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.